Corey Goldman

Integrated Immunotherapy Target Atlas for Ewing Sarcoma

Abstract Background/Aim: Ewing sarcoma is a fusion-driven malignancy with low tumor mutational burden, making recurrent tumor-associated antigens with favorable tumor-to-normal contrast central to immunotherapy development. We converted the Deng et al.-defined 32-gene Ewing Sarco...